A Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of Lisdexamfetamine Dimesylate in Adults with Moderate to Severe Binge Eating Disorder

被引：0
|
作者：
Hudson, James [1 ]
McElroy, Susan [1 ]
Ferreira-Cornwell, Celeste [1 ]
Radewonuk, Jana [1 ]
Gasior, Maria [1 ]
机构：
[1] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2015年 / 40卷
关键词：
binge-eating disorder; eating disorders; randomised clinical trial; Lisdexamfetamine;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M47
引用
收藏
页码：S135 / S136
页数：2
相关论文
共 50 条
  • [1] LISDEXAMFETAMINE DIMESYLATE IN ADULTS WITH MODERATE-TO-SEVERE BINGE EATING DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL STUDY
    Naser, N.
    Hudson, J.
    McElroy, S.
    Ferreira-Cornwell, M. C.
    Radewonuk, J.
    Gasior, M.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 163 - 163
  • [2] Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder
    McElroy, Susan L.
    Hudson, James I.
    Gasior, Maria
    Herman, Barry K.
    Radewonuk, Jana
    Wilfley, Denise
    Busner, Joan
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2017, 50 (08) : 884 - 892
  • [3] Topiramate for the treatment of moderate to severe binge eating disorder associated with obesity - A double-blind, placebo-controlled study
    McElroy, S
    Hudson, JI
    Capece, JA
    Beyers, K
    Fisher, AC
    Rosenthal, NR
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S138 - S138
  • [4] Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial
    Guerdjikova, Anna I.
    Mori, Nicole
    Blom, Thomas J.
    Keck, Paul E., Jr.
    Williams, Stephanie L.
    Welge, Jeffrey A.
    McElroy, Susan L.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (05) : 382 - 391
  • [5] LISDEXAMFETAMINE DIMESYLATE FOR ADULTS WITH MODERATE TO SEVERE BINGE EATING DISORDER: RESULTS OF TWO RANDOMIZED CONTROLLED SAFETY AND EFFICACY TRIALS
    Naser, N.
    McElroy, S.
    Hudson, J.
    Ferreira-Cornwell, M. C.
    Radewonuk, J.
    Gasior, M.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2015, 49 : 116 - 116
  • [6] Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Adler, Lenard A.
    Goodman, David W.
    Kollins, Scott H.
    Weisler, Richard H.
    Krishnan, Suma
    Zhang, Yuxin
    Biederman, Joseph
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1364 - +
  • [7] Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
    Susan L McElroy
    James Hudson
    M Celeste Ferreira-Cornwell
    Jana Radewonuk
    Timothy Whitaker
    Maria Gasior
    Neuropsychopharmacology, 2016, 41 : 1251 - 1260
  • [8] A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder
    Appolinario, JC
    Bacaltchuk, J
    Sichieri, R
    Claudino, AM
    Godoy-Matos, A
    Morgan, C
    Zanella, MT
    Coutinho, W
    ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) : 1109 - 1116
  • [9] Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
    McElroy, Susan L.
    Hudson, James
    Ferreira-Cornwell, M. Celeste
    Radewonuk, Jana
    Whitaker, Timothy
    Gasior, Maria
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (05) : 1251 - 1260
  • [10] Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial
    Grilo, Carlos M.
    Ivezaj, Valentina
    Yurkow, Sydney
    Tek, Cenk
    Wiedemann, Ashley A.
    Gueorguieva, Ralitza
    PSYCHOLOGICAL MEDICINE, 2024, 54 (12) : 3334 - 3344
12345